about
US valuation of health outcomes measured using the PROMIS-29.Exclusion Criteria in National Health State Valuation Studies: A Systematic Review.Demographic differences in health preferences in the United States.The Value Adults Place on Child Health and Functional StatusPotential Impact of Biologically Derived Hyaluronic Acid on Quality of Life in Patients with Knee Osteoarthritis in the United States.An Australian discrete choice experiment to value eq-5d health states.Comparing and transforming PROMIS utility values to the EQ-5D.Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.
P2860
Q27308886-397E8C33-E1E3-4221-9D0C-08F30097330CQ30252110-4BAE3C7C-BACA-424D-8949-FD7D9FB75297Q33650913-D3358AD5-9569-4797-AA4E-07315348730EQ35763215-20224D73-FE2B-41BB-8ECA-321924BFA337Q37447599-13A7C717-78D3-4796-9278-892DD7210B60Q43891957-0BDC2EE6-BC40-4E64-B35B-8CD7E3474411Q48372464-31329B91-FB39-41E1-AB58-C6CD1C8FF5D7Q48431783-8BC1858F-CC7D-440A-9035-B24A2D3EBA84
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Revisiting United States valuation of EQ-5D states.
@ast
Revisiting United States valuation of EQ-5D states.
@en
type
label
Revisiting United States valuation of EQ-5D states.
@ast
Revisiting United States valuation of EQ-5D states.
@en
prefLabel
Revisiting United States valuation of EQ-5D states.
@ast
Revisiting United States valuation of EQ-5D states.
@en
P2860
P1476
Revisiting United States valuation of EQ-5D states
@en
P2093
Benjamin M Craig
P2860
P304
P356
10.1016/J.JHEALECO.2011.07.009
P577
2011-07-21T00:00:00Z